Literature DB >> 17251565

Pregnancy increases the risk of mortality in West Nile virus-infected mice.

Laura Córdoba1, Estela Escribano-Romero, Antonio Garmendia, Juan-Carlos Saiz.   

Abstract

West Nile fever outbreaks in the USA have caused over 700 human deaths, primarily due to neurological disease. The usual transmission route of West Nile virus (WNV) involves mosquito bites; however, alternative routes, including intrauterine infection, have also been reported. Here, the pathogenicity of WNV in mice during gestation has been investigated. An extremely high mortality rate was observed in pregnant mice (98 %, 60/61) compared with non-pregnant mice (52 %, 28/53; P<0.001), independent of the infecting dose or the week of pregnancy. Antibody titres were similar between pregnant and non-pregnant mice and between surviving and non-surviving animals. WNV RNA titres in brains were also similar between pregnant and non-pregnant mice. WNV RNA could be detected in placentas and fetuses. These observations suggest strongly that, in the mouse model, pregnancy increases the risk of severe WNV infection and may help to understand the pathogenic mechanisms involved in WNV infection during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251565     DOI: 10.1099/vir.0.82439-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

Review 1.  Consequences of congenital Zika virus infection.

Authors:  Derek J Platt; Jonathan J Miner
Journal:  Curr Opin Virol       Date:  2017-11-06       Impact factor: 7.090

Review 2.  West Nile virus: A re-emerging pathogen revisited.

Authors:  Miguel A Martín-Acebes; Juan-Carlos Saiz
Journal:  World J Virol       Date:  2012-04-12

3.  Inhibition of enveloped virus infection of cultured cells by valproic acid.

Authors:  Angela Vázquez-Calvo; Juan-Carlos Saiz; Francisco Sobrino; Miguel A Martín-Acebes
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

Review 4.  Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes.

Authors:  Alice Panchaud; Miloš Stojanov; Anne Ammerdorffer; Manon Vouga; David Baud
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

5.  Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts.

Authors:  Miguel Rodríguez-Pulido; Miguel A Martín-Acebes; Estela Escribano-Romero; Ana-Belén Blázquez; Francisco Sobrino; Belén Borrego; Margarita Sáiz; Juan-Carlos Saiz
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

6.  West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids.

Authors:  Miguel A Martín-Acebes; Ana-Belén Blázquez; Nereida Jiménez de Oya; Estela Escribano-Romero; Juan-Carlos Saiz
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

7.  Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian Drugs.

Authors:  Ana B Blázquez; Miguel A Martín-Acebes; Juan-Carlos Saiz
Journal:  Front Microbiol       Date:  2016-03-07       Impact factor: 5.640

8.  West nile virus infection in pregnancy.

Authors:  Robert D Stewart; Stefanie N Bryant; Jeanne S Sheffield
Journal:  Case Rep Infect Dis       Date:  2013-03-04

9.  A single amino acid substitution in the core protein of West Nile virus increases resistance to acidotropic compounds.

Authors:  Miguel A Martín-Acebes; Ana-Belén Blázquez; Nereida Jiménez de Oya; Estela Escribano-Romero; Pei-Yong Shi; Juan-Carlos Saiz
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

10.  Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus.

Authors:  Teresa Merino-Ramos; Ana-Belén Blázquez; Estela Escribano-Romero; Rodrigo Cañas-Arranz; Francisco Sobrino; Juan-Carlos Saiz; Miguel A Martín-Acebes
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.